Nothing Special   »   [go: up one dir, main page]

ATE198744T1 - Benzimidazol-, benzoxazol- und benzothiazolderivate, welche als inhibitoren des interleukin 1beta verwendbar sind - Google Patents

Benzimidazol-, benzoxazol- und benzothiazolderivate, welche als inhibitoren des interleukin 1beta verwendbar sind

Info

Publication number
ATE198744T1
ATE198744T1 AT97401789T AT97401789T ATE198744T1 AT E198744 T1 ATE198744 T1 AT E198744T1 AT 97401789 T AT97401789 T AT 97401789T AT 97401789 T AT97401789 T AT 97401789T AT E198744 T1 ATE198744 T1 AT E198744T1
Authority
AT
Austria
Prior art keywords
optionally substituted
aryl
benzoxazole
benzimidazole
alkyl
Prior art date
Application number
AT97401789T
Other languages
English (en)
Inventor
Nanteuil Guillaume De
Bernard Portevin
Jacqueline Bonnet
Armel Fradin
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Application granted granted Critical
Publication of ATE198744T1 publication Critical patent/ATE198744T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/10—Radicals substituted by halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/12—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/14—Radicals substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
AT97401789T 1996-07-26 1997-07-24 Benzimidazol-, benzoxazol- und benzothiazolderivate, welche als inhibitoren des interleukin 1beta verwendbar sind ATE198744T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9609416A FR2751649B1 (fr) 1996-07-26 1996-07-26 Nouveaux derives de benzimidazole, de benzoxazole et de benzothiazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
ATE198744T1 true ATE198744T1 (de) 2001-02-15

Family

ID=9494506

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97401789T ATE198744T1 (de) 1996-07-26 1997-07-24 Benzimidazol-, benzoxazol- und benzothiazolderivate, welche als inhibitoren des interleukin 1beta verwendbar sind

Country Status (19)

Country Link
US (1) US5972968A (de)
EP (1) EP0820990B1 (de)
JP (1) JPH1067753A (de)
CN (1) CN1090620C (de)
AT (1) ATE198744T1 (de)
AU (1) AU715751B2 (de)
BR (1) BR9704076A (de)
CA (1) CA2211444C (de)
DE (1) DE69703915T2 (de)
DK (1) DK0820990T3 (de)
ES (1) ES2155660T3 (de)
FR (1) FR2751649B1 (de)
GR (1) GR3035434T3 (de)
HU (1) HUP9701297A1 (de)
NO (1) NO308602B1 (de)
NZ (1) NZ328431A (de)
PL (1) PL321336A1 (de)
PT (1) PT820990E (de)
ZA (1) ZA976655B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9602029D0 (en) * 1996-02-01 1996-04-03 Fujisawa Pharmaceutical Co New heterocyclic compounds
FR2766822B1 (fr) * 1997-07-30 2001-02-23 Adir Nouveaux derives de benzimidazole, de benzoxazole et de benzothiazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
US6248770B1 (en) * 1998-07-09 2001-06-19 Boehringer Ingelheim Pharma Kg Benzimidazoles having antithrombotic activity
EP1123703B1 (de) * 1998-10-23 2004-04-14 Toray Industries, Inc. Immunmodulierende arzneimittelzusammenstellung
US6451832B2 (en) 1999-12-23 2002-09-17 Boehringer Ingelheim Pharma Kg Benzimidazoles with antithrombotic activity
WO2001054688A1 (en) 2000-01-28 2001-08-02 Merck & Co., Inc. Treatment or prevention of prostate cancer with a cox-2 selective inhibiting drug
US6660858B2 (en) 2001-03-28 2003-12-09 Lion Bioscience Ag 2-aminobenzoxazole derivatives and combinatorial libraries thereof
JP2008518905A (ja) * 2004-11-02 2008-06-05 ファイザー株式会社 スルホニルベンゾイミダゾール誘導体
TW200804345A (en) * 2005-08-30 2008-01-16 Novartis Ag Substituted benzimidazoles and methods of preparation
FR2891273B1 (fr) * 2005-09-27 2007-11-23 Aventis Pharma Sa NOUVEAUX DERIVES BENZIMIDAZOLES ET BENZOTHIAZOLES, LEUR PREPARATION ET LEUR UTILISATION PHARMACEUTIQUE NOTAMMENT COMME INHIBITEURS DE CMet
MX2011007663A (es) * 2009-01-22 2011-08-15 Raqualia Pharma Inc Compuestos de sulfona heterociclica, saturada y sustituida en n, con actividad agonistica del receptor de cb2.
BRPI1006113A2 (pt) 2009-03-05 2016-02-16 Daiichi Sankyo Co Ltd "derivado de piridina".
BR112012010738A2 (pt) 2009-11-06 2019-09-24 Univ Vanderbilt ''aril e heteroaril sulfonas como potenciadores alostéricos de mglur4,composições e métodos de tratamento de disfunção neurológica''
TW201534597A (zh) * 2013-06-20 2015-09-16 Ab Science 作為選擇性蛋白質激酶抑制劑之苯并咪唑衍生物

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2290430A1 (fr) * 1974-11-06 1976-06-04 Aries Robert Nouveau mode de synthese d'esters carbamiques derives du benzimidazole
LU75684A1 (de) * 1976-08-27 1978-04-13
EP0023022B1 (de) * 1979-07-20 1984-04-11 Ciba-Geigy Ag Cumarinverbindungen, Verfahren zu deren Herstellung sowie die dafür verwendeten Zwischenprodukte an sich und ihre Verwendung zum Färben oder Bedrucken von Textilien
GR78209B (de) * 1982-04-15 1984-09-26 May & Baker Ltd
US4430502A (en) * 1982-08-13 1984-02-07 The Upjohn Company Pyridinyl substituted benzimidazoles and quinoxalines
NZ221729A (en) * 1986-09-15 1989-07-27 Janssen Pharmaceutica Nv Imidazolyl methyl-substituted benzimidazole derivatives and pharmaceutical compositions
IT1222412B (it) * 1987-07-31 1990-09-05 Chiesi Farma Spa Tiometil e sulfinil metil derivati ad azione antisecretiva acida gastrica,loro procedimento di preparazione e composizioni farmaceutiche che li contengono
JP2869561B2 (ja) * 1989-05-22 1999-03-10 大塚製薬株式会社 血小板粘着抑制剤
JPH06759B2 (ja) * 1989-09-22 1994-01-05 ファイザー製薬株式会社 新規なベンゾイミダゾール化合物
IE910278A1 (en) * 1990-02-16 1991-08-28 Ici Plc Heterocyclic compounds
JPH08294229A (ja) * 1995-04-20 1996-11-05 Nec Corp 半導体集積回路装置
JPH09169729A (ja) * 1995-12-19 1997-06-30 Green Cross Corp:The 非ペプチド型インターロイキン８拮抗剤
JP3243733B2 (ja) * 1996-08-07 2002-01-07 雪印乳業株式会社 新規イソキノリン誘導体
JP2007024865A (ja) * 2005-06-17 2007-02-01 Renesas Technology Corp 半導体装置
KR100861371B1 (ko) * 2007-06-25 2008-10-01 주식회사 하이닉스반도체 온도센서 및 이를 이용한 반도체 메모리 장치
JP2009058438A (ja) * 2007-08-31 2009-03-19 Toshiba Corp 温度検出回路
JP5888009B2 (ja) * 2012-03-08 2016-03-16 株式会社豊田中央研究所 温度センサ回路

Also Published As

Publication number Publication date
ZA976655B (en) 1998-02-10
GR3035434T3 (en) 2001-05-31
ES2155660T3 (es) 2001-05-16
HU9701297D0 (en) 1997-09-29
NO973443D0 (no) 1997-07-25
FR2751649B1 (fr) 1998-08-28
CN1090620C (zh) 2002-09-11
AU3017297A (en) 1998-02-05
PL321336A1 (en) 1998-02-02
NO308602B1 (no) 2000-10-02
EP0820990A2 (de) 1998-01-28
DE69703915D1 (de) 2001-02-22
NZ328431A (en) 1997-12-19
JPH1067753A (ja) 1998-03-10
EP0820990A3 (de) 1998-07-29
HUP9701297A1 (hu) 1999-09-28
DK0820990T3 (da) 2001-05-07
US5972968A (en) 1999-10-26
NO973443L (no) 1998-01-27
FR2751649A1 (fr) 1998-01-30
EP0820990B1 (de) 2001-01-17
PT820990E (pt) 2001-06-29
CA2211444C (fr) 2002-07-09
AU715751B2 (en) 2000-02-10
CN1174192A (zh) 1998-02-25
DE69703915T2 (de) 2001-08-02
CA2211444A1 (fr) 1998-01-26
BR9704076A (pt) 1999-05-11

Similar Documents

Publication Publication Date Title
ATE198744T1 (de) Benzimidazol-, benzoxazol- und benzothiazolderivate, welche als inhibitoren des interleukin 1beta verwendbar sind
DK0447285T3 (da) Nephtalenderivater, fremgangsmåde til fremstilling heraf og farmaceutiske midler indeholdende dem
ATE269290T1 (de) Benzoylderivate
CZ83996A3 (en) Hydroxy substituted azetidine compounds and their use as hypocholesterol agents
ES2062374T3 (es) Heteroarilpiperazinas, agentes antipsicoticos.
DK0903347T3 (da) Hidtil ukendte cyclodepsipeptid PF1022-derivater
ES551944A0 (es) Procedimiento para preparar 1,3,4,5-tetrahidro-benz cd indolaminas oxigenadas en posicion 6
TR25111A (tr) Kontrast ortami
MX9303587A (es) Producto para el cuidado de lentes de contacto, para lentes de contacto duros o blandos.
HUP0003475A2 (hu) Neutrofil-elasztáz gátló hatású pirrolo-pirrolon-származékok, eljárás előállításukra, alkalmazásuk és az ezeket tartalmazó gyógyszerkészítmények
YU47478B (sh) Jedinjenja beta-fenoksinitrili i postupci za njihovo dobijanje
FI892681A0 (fi) Nya jodade icke-joniska trijodbenzenfoereningar och dessa innehaollande kontrastmedel.
DE3689987D1 (de) Desinfektion von Kontaktlinsen.
DE3867583D1 (de) Aminoalkyl-substituierte, heterozyklische schwefelverbindungen.
NO972943D0 (no) 4-amino-2-ureido-pyrimidin-5-karboksylsyreamider, fremgangsmåter for deres fremstilling, legemidler inneholdende disse forbindelsene og deres anvendelse
PT1120415E (pt) Compostos de isoxazoliltiofeno substituido
NO972942L (no) 4-amino-2-ureido-pyrimidin-5-karboksylsyreamider, fremgangsmåter for deres fremstilling, legemidler inneholdende disse forbindelsene og deres anvendelse
HUP9903036A2 (hu) Mappia foetidából izolált kamptotecinvázas vegyületek, alkalmazásuk új gyógyszerekben szintonokként, valamint terápiás szerekként

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee